June 24, 2021
Video
COVID-19 response restrained flu outbreaks last year. An expert explains his concern that won't be enough this winter.
An interview with a study author on new Novavax-Seqirus co-administration trial data, and the future concerns of circulating COIVD-19 and influenza.
June 23, 2021
Article
New ASM data show indoor environments are associated with quick and frequent pathogen contamination of the common respiratory device.
June 22, 2021
An interview with a study author on unique associations between county infrastructures and COVID-19 fatality rates.
The device may help clinicians differentiate between past infections and co-infections during the upcoming flu season.
Examining pharmacological management in COVID-19 patients with ARDS requiring antifungal therapy during extracorporeal life support.
June 21, 2021
New findings on an available 15-minute test show an approximate 81% sensitivity in detection of SARS-CoV-2.
New findings from the ASM 2021 World Microbe Forum suggest the emergency-authorized platform can capably detected the highly transmissible UK-borne variant.
June 15, 2021
Five people in 4 US states in the 20-21 influenza season contracted influenza A virus variants commonly spread among pigs, but without person-to-person spread.
June 13, 2021
Cartesian Therapeutics has created its therapy, Descartes-30, the first RNA cell therapy for acute respiratory distress syndrome (ARDS), and the company is now recruiting for a clinical trial.
